An FDA spokesperson told media outlets that the agency anticipates the EpiPen shortage to be short-term. "You can.draw up a little bit to give to the patient to take home until they get their prescription".
"We checked again today to see if we could get more and they are on back order again", says pharmacist, John Forbes.
The U.S. Food and Drug Administration (FDA) has declared a nationwide shortage of an injectable drug that prevents life-threatening allergic reactions.
Mylan said it is receiving "continual" supply from Pfizer unit Meridian Medical Technologies, which produces all EpiPens sold globally at a single plant near St. Louis.
Eden Hazard On Bench - Chelsea Team vs Huddersfield Town Confirmed
N'Golo Kante was back to his masterful self against the Champions League finalists. This match will be the 66th time both of them will face each other.
Raptors Season Ends Once Again With More Questions Than Answers
The Raptors became the third National Basketball Association team to be swept in a series before the conference-final stage. On Monday night, the LeBron James-led Cleveland Cavaliers knocked out the Toronto Raptors for the third straight season.
SpaceX's Block 5 Falcon 9 Rocket To Undergo Test Launch Tomorrow
This is the final iteration of the Falcon 9 rocket, one that could possibly be reused up to 10 times before needing refurbishment. As the cost of launches drops, more budding space programs can get a leg up when it comes to getting satellites into space.
In a statement released Wednesday, Mylan said it is now receiving continual supply from its manufacturing partner and is expediting shipments to wholesales upon receipt. The company didn't immediately respond to follow-up questions about how much product it was shipping, or if it had resolved issues related to the FDA warnings about manufacturing issues.
EpiPen supply constraints have been reported in Canada and Britain due to manufacturing issues.
"It;s of serious concern because a lot of times these are lifesaving medications people need them right now".
The drugmaker told investors it was still on track for product launches this year including the generic version of asthma drug Advair. Pfizer manufactures both the branded and authorized generic versions and Mylan is the distributor. Adjusted earnings-per-share were 96 cents, above the FactSet consensus of 95 cents. "This will include a list of epinephrine auto-injector products that are available from other manufacturers as well as contact information for consumers and health care providers", Smith Dyer said.